SEC Form 4 · accession 0001127602-17-003387
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BIOGEN INC.
10% Owner
Period of report
Feb 1, 2017
Accepted (ET)
Feb 1, 2017 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 1, 2017 | J | 107,975,968 | $0.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Biogen Inc. distributed the shares to its shareholders on a pro rata basis in connection with the separation of the Issuer from Biogen Inc. on February 1, 2017.
- F2On January 31, 2017, the 1,000 shares of common stock of the Issuer, issued and outstanding as of such date, were reclassified and subdivided into 107,975,968 shares resulting in the reporting person's ownership of a total of 107,975,968 shares of common stock.